Spots Global Cancer Trial Database for Study of Imatinib in Children With Neurofibromatosis and Airway Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Imatinib in Children With Neurofibromatosis and Airway Tumors
Official Title: Phase 2 Study of Imatinib in Children With Neurofibromatosis and Airway Tumors
Study ID: NCT03688568
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to look at a subset of plexiform neurofibromas and determine if the airway tumors are more sensitive to imatinib therapy. Funding Source - FDA OOPD
Detailed Description:
Keywords
Eligibility
Minimum Age: 6 Months
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Locations
Riley Hospital for Children - Indiana University, Indianapolis, Indiana, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
